|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/202 | |
| A01N 37/00 | |||
| A61K 31/20 | |||
| A61K 31/232 | |||
| A61P 3/06 | |||
| A61P 9/00 | |||
| A61P 9/10 | |||
| A61K 45/06 | |||
| A61K 9/48 |
| (11) | Number of the document | 2542060 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11751431.5 |
| Date of filing the European patent application | 2011-03-04 | |
| (97) | Date of publication of the European application | 2013-01-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/027218 |
| Date | 2011-03-04 |
| (87) | Number | WO 2011/109724 |
| Date | 2011-09-09 |
| (30) | Number | Date | Country code |
| 310443 P | 2010-03-04 | US |
| (72) |
ROWE, Jonathan, US
|
| (73) |
Amarin Pharmaceuticals Ireland Limited,
2 Pembroke House Upper Pembroke Street 28-32, Dublin 2,
IE
|
| (54) | COMPOSITIONS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE |
| COMPOSITIONS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE |